Moroxite Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $2.22M

  • Investors
  • 4

Moroxite General Information

Description

Developer of a regenerative medicine designed for prolonged release of hydroxyapatite binding drugs in fragility fractures. The company focuses on the development of a fracture fixation medication that delivers hydroxyapatite particles at the interface of bone for improving implant anchorage leading to fewer fixation failures and re-operations, enabling osteoporotic patients for reduced societal costs and better quality of life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Kung Oskars Väg 11 C
  • 222 35 Lund
  • Sweden
+46 073-535
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Kung Oskars Väg 11 C
  • 222 35 Lund
  • Sweden
+46 073-535

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Moroxite Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 24-Apr-2025 $2.22M Completed Clinical Trials - General
2. Early Stage VC 16-Feb-2022 Completed Clinical Trials - General
1. Spin-Off 01-Dec-2021 Completed Clinical Trials - General
To view Moroxite’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Moroxite Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Moroxite Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Sciety Venture Capital Minority
Almi Invest Venture Capital Minority
Fåhraeus Startup and Growth Venture Capital Minority
Moroxite. Corporation Minority
To view Moroxite’s complete investors history, request access »

Moroxite FAQs

  • When was Moroxite founded?

    Moroxite was founded in 2021.

  • Where is Moroxite headquartered?

    Moroxite is headquartered in Lund, Sweden.

  • What is the size of Moroxite?

    Moroxite has 9 total employees.

  • What industry is Moroxite in?

    Moroxite’s primary industry is Drug Discovery.

  • Is Moroxite a private or public company?

    Moroxite is a Private company.

  • What is Moroxite’s current revenue?

    The current revenue for Moroxite is .

  • How much funding has Moroxite raised over time?

    Moroxite has raised $3.3M.

  • Who are Moroxite’s investors?

    Sciety, Almi Invest, Fåhraeus Startup and Growth, and Moroxite. have invested in Moroxite.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process